Skip to main content
    K

    Kewaunee Scientific Corporation (KEQU)

    Official site

    CONSUMER CYCLICAL • FURNISHINGS, FIXTURES & APPLIANCES • NASDAQ

    $35.06
    -0.64 (-1.79%)

    Market Cap: $103.36M

    Last updated: Nov 17, 2026 at 3:04 AM ET

    Kewaunee Scientific Corporation (KEQU) Financials: Revenue, Profit and Cash Flow

    Updated Sep 9, 2026. Financial statements from company filings, amounts in US dollars.

    Kewaunee Scientific reported revenue of $282.00M for the fiscal year ended Apr 30, 2026, up 17.3% from the year before. That year, net income was $10.46M with a net margin of 3.7%, operating cash flow was $18.63M and free cash flow was $14.70M. The quarter ended Jul 31, 2026 had revenue of $66.32M and net income of $1.84M.

    Revenue and Margins

    The operating margin was 5.9% in the fiscal year ended Apr 2026. Over the 9 years to Apr 2026, revenue grew from $138.56M, a compound annual rate of 8.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Apr 2026$282.00M+17.3%28.5%5.9%3.7%
    Apr 2025$240.47M+18.0%28.6%7.4%4.8%
    Apr 2024$203.75M-7.2%25.5%9.0%9.4%
    Apr 2023$219.49M+30.0%16.2%2.4%0.6%
    Apr 2022$168.87M+14.5%14.3%-1.5%-3.6%
    Apr 2021$147.47M0.0%16.3%-0.9%-2.4%
    Apr 2020$147.54M+0.7%15.9%-1.6%-3.1%
    Apr 2019$146.55M-7.3%17.3%1.4%1.2%
    Apr 2018$158.05M+14.1%20.3%6.3%3.5%
    Apr 2017$138.56MN/A19.2%4.7%3.3%
    Annual, fiscal years ended Apr 2017 to Apr 2026

    Income Statement

    In the fiscal year ended Apr 2026, net income fell 9.7% from the year before. In the quarter ended Jul 2026, net income fell 41.8% from the same quarter a year earlier.

    Annual

    Line itemApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
    Revenue$282.00M$240.47M$203.75M$219.49M$168.87M$147.47M$147.54M$146.55M$158.05M$138.56M
    Cost of revenue$201.56M$171.62M$151.70M$183.91M$144.65M$123.48M$124.11M$121.23M$125.89M$111.95M
    Gross profit$80.44M$68.86M$52.05M$35.59M$24.22M$23.99M$23.43M$25.32M$32.16M$26.61M
    Operating income$16.71M$17.76M$18.28M$5.36M-$2.61M-$1.32M-$2.35M$2.11M$9.92M$6.54M
    Net income$10.46M$11.58M$19.06M$1.36M-$6.00M-$3.61M-$4.62M$1.69M$5.46M$4.62M
    EBITDA$24.44M$22.98MN/A$9.17M$916.00K$459.00K$281.00K$5.07M$12.68M$9.74M
    Fiscal years ended Apr 2017 to Apr 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Revenue$66.32M$71.40M$69.40M$70.10M$71.10M$77.15M$67.17M$47.76M$48.39M$56.70M$46.78M$50.44M
    Gross profit$19.64M$21.25M$18.55M$19.72M$20.93M$24.04M$18.38M$13.95M$12.49M$14.64M$12.03M$13.47M
    Operating income$3.16M$5.22M$2.58M$4.11M$4.81M$8.50M$2.25M$4.43M$2.58M$5.56M$3.81M$5.11M
    Net income$1.84M$3.69M$1.08M$2.54M$3.16M$4.95M$1.38M$3.02M$2.24M$11.18M$2.53M$2.83M
    Last 12 quarters

    Balance Sheet

    As of Apr 2026, total debt of $19.77M exceeded cash and equivalents by $9.82M.

    Annual

    Line itemApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
    Total assets$178.31M$194.65M$134.77M$118.90M$118.77M$89.38M$83.93M$87.22M$85.08M$80.92M
    Current assets$105.40M$118.36M$96.82M$87.92M$91.56M$60.46M$54.23M$65.36M$64.39M$59.81M
    Cash and equivalents$9.95M$14.94M$23.27M$8.08M$4.43M$5.21M$4.37M$10.65M$9.72M$12.51M
    Total liabilities$101.50M$128.41M$78.56M$80.41M$82.59M$47.90M$45.23M$39.52M$36.89M$37.66M
    Short-term debt$4.97M$3.89M$3.10M$3.59M$1.59M$6.83M$4.72M$10.68M$5.05M$4.51M
    Long-term debt$14.80M$33.95M$0N/AN/AN/AN/A$97.00K$1.26M$2.43M
    Shareholder equity$74.72M$64.46M$54.76M$37.41M$35.69M$41.24M$38.41M$47.10M$47.73M$42.88M
    Fiscal years ended Apr 2017 to Apr 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total assets$175.80M$178.31M$175.96M$189.07M$193.49M$194.65M$189.15M$134.48M$132.02M$134.77M$126.31M$121.71M
    Total liabilities$98.58M$101.50M$103.43M$117.36M$124.62M$128.41M$127.03M$73.82M$74.50M$78.56M$80.96M$78.29M
    Cash and equivalents$8.25M$11.62M$8.15M$12.59M$19.49M$14.94M$9.45M$25.96M$24.21M$25.94M$21.31M$13.72M
    Shareholder equity$75.00M$74.72M$70.67M$69.85M$67.08M$64.46M$60.80M$59.33M$56.02M$54.76M$44.08M$42.11M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Apr 2026, free cash flow was 78.9% of operating cash flow. Dividends came to 2.3% of it, with no share repurchases.

    Annual

    Line itemApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
    Operating cash flow$18.63M$14.78M$19.56M-$3.79M-$7.88M$912.00K$4.16M$2.49M$3.18M$11.66M
    Capital expenditures$3.94M$2.17M$4.37M$4.15M$1.91M$2.40M$2.46M$4.21M$3.40M$2.61M
    Free cash flow$14.70M$12.62M$15.19M-$7.94M-$9.79M-$1.49M$1.70M-$1.72M-$212.00K$9.05M
    Dividends paid$339.00K$261.00K$0N/AN/A$108.00K$1.37M$2.08M$1.87M$1.63M
    Share repurchases$0$1.60M$2.00M$0N/AN/AN/AN/AN/AN/A
    Investing cash flow-$3.94M-$30.90M-$4.37M-$4.15M-$1.91M-$2.40M-$2.46M-$4.21M-$3.40M-$2.48M
    Financing cash flow-$19.33M$7.41M-$3.01M$14.93M$11.03M$1.98M-$7.46M$2.33M-$2.48M-$2.08M
    Fiscal years ended Apr 2017 to Apr 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Operating cash flow$1.98M$5.46M$11.65M-$4.26M$5.79M$9.41M-$2.27M$8.44M-$794.00K$1.15M$9.50M$747.00K
    Capital expenditures$772.00K$928.00K$668.00K$1.57M$771.00K$516.00K$689.00K$683.00K$278.00K$979.00K$475.00K$1.26M
    Free cash flow$1.20M$4.53M$10.98M-$5.83M$5.02M$8.89M-$2.96M$7.75M-$1.07M$166.00K$9.03M-$518.00K
    Last 12 quarters

    Frequently Asked Questions About KEQU

    What is Kewaunee Scientific's annual revenue?

    Kewaunee Scientific reported revenue of $282.00M for the fiscal year ended Apr 30, 2026.

    How fast is Kewaunee Scientific's revenue growing?

    Revenue was up 17.3% for the fiscal year ended Apr 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 8.7%.

    Is Kewaunee Scientific profitable?

    Yes. Kewaunee Scientific reported net income of $10.46M for the fiscal year ended Apr 30, 2026, with a net margin of 3.7%.

    How much free cash flow does KEQU generate?

    For the fiscal year ended Apr 30, 2026, operating cash flow of $18.63M minus capital expenditures of $3.94M produced free cash flow of $14.70M.

    How much debt does Kewaunee Scientific have?

    The balance sheet dated Apr 30, 2026 reported long-term debt of $14.80M, short-term debt of $4.97M and cash and equivalents of $9.95M.